Next Article in Journal
Interaction of Thalassia testudinum Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity
Previous Article in Journal
Potential Anti-Aging Substances Derived from Seaweeds

Exploiting Mannuronan C-5 Epimerases in Commercial Alginate Production

Department of Biotechnology and Nanomedicine, SINTEF Industry, Richard Birkelands vei 3B, N-7034 Trondheim, Norway
Department of Biotechnology and Food Science, Norwegian University of Science and Technology, NTNU, Sem Sælands vei 6-8, N-7491 Trondheim, Norway
AlgiPharma AS, Industriveien 33, N-1337 Sandvika, Norway
Author to whom correspondence should be addressed.
Mar. Drugs 2020, 18(11), 565;
Received: 28 October 2020 / Revised: 9 November 2020 / Accepted: 12 November 2020 / Published: 18 November 2020
Alginates are one of the major polysaccharide constituents of marine brown algae in commercial manufacturing. However, the content and composition of alginates differ according to the distinct parts of these macroalgae and have a direct impact on the concentration of guluronate and subsequent commercial value of the final product. The Azotobacter vinelandii mannuronan C-5 epimerases AlgE1 and AlgE4 were used to determine their potential value in tailoring the production of high guluronate low-molecular-weight alginates from two sources of high mannuronic acid alginates, the naturally occurring harvested brown algae (Ascophyllum nodosum, Durvillea potatorum, Laminaria hyperborea and Lessonia nigrescens) and a pure mannuronic acid alginate derived from fermented production of the mutant strain of Pseudomonas fluorescens NCIMB 10,525. The mannuronan C-5 epimerases used in this study increased the content of guluronate from 32% up to 81% in both the harvested seaweed and bacterial fermented alginate sources. The guluronate-rich alginate oligomers subsequently derived from these two different sources showed structural identity as determined by proton nuclear magnetic resonance (1H NMR), high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) and size-exclusion chromatography with online multi-angle static laser light scattering (SEC-MALS). Functional identity was determined by minimum inhibitory concentration (MIC) assays with selected bacteria and antibiotics using the previously documented low-molecular-weight guluronate enriched alginate OligoG CF-5/20 as a comparator. The alginates produced using either source showed similar antibiotic potentiation effects to the drug candidate OligoG CF-5/20 currently in development as a mucolytic and anti-biofilm agent. These findings clearly illustrate the value of using epimerases to provide an alternative production route for novel low-molecular-weight alginates. View Full-Text
Keywords: seaweed and bacterial alginate; mannuronan C-5 epimerases; guluronate oligomers; potentiation of antibiotic effect seaweed and bacterial alginate; mannuronan C-5 epimerases; guluronate oligomers; potentiation of antibiotic effect
Show Figures

Figure 1

MDPI and ACS Style

Tøndervik, A.; Aarstad, O.A.; Aune, R.; Maleki, S.; Rye, P.D.; Dessen, A.; Skjåk-Bræk, G.; Sletta, H. Exploiting Mannuronan C-5 Epimerases in Commercial Alginate Production. Mar. Drugs 2020, 18, 565.

AMA Style

Tøndervik A, Aarstad OA, Aune R, Maleki S, Rye PD, Dessen A, Skjåk-Bræk G, Sletta H. Exploiting Mannuronan C-5 Epimerases in Commercial Alginate Production. Marine Drugs. 2020; 18(11):565.

Chicago/Turabian Style

Tøndervik, Anne, Olav A. Aarstad, Randi Aune, Susan Maleki, Philip D. Rye, Arne Dessen, Gudmund Skjåk-Bræk, and Håvard Sletta. 2020. "Exploiting Mannuronan C-5 Epimerases in Commercial Alginate Production" Marine Drugs 18, no. 11: 565.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop